Superworth

Praxis Precision Medicines EPS PRAX

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
−$12.92
Latest quarter, Q2 FY26
−$2.87
Fiscal year 2025
−$13.45

Praxis Precision Medicines' earnings per share was −$12.92 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$2.87.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$13.45n/a
FY2024−$10.27n/a
FY2023−$23.65n/a
FY2022−$69.90n/a
FY2021−$58.35n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$2.87n/a−$12.92
Q1 FY26−$3.20n/a−$13.36
Q4 FY25−$3.49n/a−$13.45
Q3 FY25−$3.36n/a−$12.90
Q2 FY25−$3.31n/a−$12.29
Q1 FY25−$3.29n/a−$10.72
Q4 FY24−$2.94n/a−$10.27
Q3 FY24−$2.75n/a−$10.30
Q2 FY24−$1.74n/a−$10.27
Q1 FY24−$2.84n/a−$15.91
Q4 FY23−$2.97n/a−$23.65
Q3 FY23−$2.72n/a−$33.73

Against its peers

Companies in Drug Manufacturers - General nearest Praxis Precision Medicines' size, closest first, today.

CompanyEPS, 12 monthsGrowth
PRAXPraxis Precision Medicines−$12.92
ALKSAlkermes plc.$0.38−82% a year
AMRXAmneal Pharmaceuticals$0.49+4800% a year
LGNDLigand Pharmaceuticals$9.40
TGTXTG Therapeutics$2.74+641% a year
KNSAKiniksa Pharmaceuticals International$0.97+2325% a year
PTGXProtagonist Therapeutics$1.03+47% a year
CORTCorcept Therapeutics$0.42−63% a year
BMRNBiomarin Pharmaceutical$0.37−89% a year
INDVIndivior Pharmaceuticals$2.78+227% a year
ARQTArcutis Biotherapeutics$0.22
Peer median$0.73

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Praxis Precision Medicines

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.